1.Identification of potential influencing factors associated with elimination of migraine headache in patients with PFO after percutaneous closure.
En Fa ZHAO ; Hang XIE ; Yu Shun ZHANG
Chinese Journal of Cardiology 2023;51(6):656-661
Objective: To recognize the potential factors that contribute to the eradication of migraine headache in patients with patent foramen ovale (PFO) at one year after percutaneous closure. Methods: A prospective cohort study was conducted, which enrolled patients diagnosed with migraines and PFO at the Department of Structural Heart Disease, First Affiliated Hospital of Xi'an Jiaotong University between May 2016 and May 2018. The patients were segregated into two groups based on their response to treatment, and one group showed elimination of migraines while another did not. Elimination of migraines was defined as a Migraine Disability Assessment Score (MIDAS) score of 0 at one year postoperatively. Least Absolute Shrinkage and Selection Operator (LASSO) regression model was utilized to identify the predictive variables for migraine elimination post-PFO closure. Multiple logistic regression analysis was employed to determine the independent predictive factors. Results: The study enrolled a total of 247 patients, with an average age of (37.5±13.6) years, comprising 81 male individuals (32.8%). One year after closure, 148 patients (59.9%) reported eradication of their migraines. Multivariate logistic regression analysis revealed that migraine with or without aura (OR=0.003 9, 95%CI 0.000 2-0.058 7, P=0.000 18), a history of antiplatelet medication use (OR=0.088 2, 95%CI 0.013 7-0.319 3, P=0.001 48) and resting right-to-left shunt (RLS) (OR=6.883 6, 95%CI 3.769 2-13.548 0, P<0.001) were identified as independent predictive factors for elimination of migraine. Conclusion: Migraine with or without aura, a history of antiplatelet medication use, and resting RLS are the independent prognostic factors associated with elimination of migraine. These results provide important clues for clinicians to choose the optimal treatment plan for PFO patients. However, further studies are needed to confirm these findings.
Humans
;
Male
;
Young Adult
;
Adult
;
Middle Aged
;
Foramen Ovale, Patent/surgery*
;
Prospective Studies
;
Heart Diseases
;
Hospitals
;
Migraine Disorders/surgery*
2.Surgical Management of Takayasu's Arteritis.
Jin Hyun JOH ; Duk Kyung KIM ; Kay Hyun PARK ; Dong Ik KIM
Journal of Korean Medical Science 2006;21(1):20-24
The results of surgical bypass and endarterectomy in Takayasu's arteritis (TA) were reported to be poor compared to usual atherosclerosis patients. However, if ischemic symptoms due to occlusive disease were severe, surgical procedures were inevitable. We report surgical experience of 5 patients with TA. Five women (ranged from 26 to 58 yr) were operated between June 1998 and May 2004. Three patients showed occlusion of main branches of aortic arch and had symptoms of cerebral ischemia. One patient showed near total occlusion in the midabdominal aorta and had symptoms of orthopnea and uncontrolled hypertension. One patient showed total occlusion of abdominal aorta at the level of aortic bifurcation and had a symptom of severe claudication on both legs. Bypasses from the ascending aorta to the carotid artery were performed in 3 cases. Bypass from the thoracic aorta to the left common iliac artery was performed in one case and endarterectomy of abdominal aorta in one case. The ischemic symptoms related with arterial occlusion were resolved after surgery. And the symptoms of cardiac failure disappeared. The symptomatic TA frequently required arterial reconstruction. The symptomatic improvement and excellent mid-term patency could be expected after arterial reconstruction and endarterectomy.
Adult
;
Endarterectomy, Carotid/methods
;
Female
;
Humans
;
Middle Aged
;
Migraine Disorders/etiology
;
Postoperative Complications
;
Takayasu's Arteritis/radiography/*surgery
;
Treatment Outcome
3.A Case of Successful Surgical Treatment of Migraine Headaches in a Patient with Sporadic Pulmonary Arteriovenous Malformations.
Sang Jun NA ; Hyun Min CHO ; Joon Seok PARK
Journal of Korean Medical Science 2009;24(2):330-332
Pulmonary arteriovenous malformations (PAVMs) are thin-walled aneurysms caused by abnormal communication between the pulmonary arteries and veins. Migraine headaches are sometimes the presenting clinical manifestation of PAVMs. Although embolotherapy, using detachable balloons or stainless steel coils, is generally accepted as the best choice for the treatment of multiple PAVMs, the mode of intervention for solitary PAVMs remains a subject of debate. We present a 43-yr-old woman with a 10-yr history of chronic migraines and dyspnea on exertion. She was discovered to have a large solitary centrally located PAVM, placing her at high risk of complications if she were to undergo percutaneous transcatheter embolization. She underwent successful surgical resection of her right middle lobe without complications, resulting in subsequent symptomatic improvement.
Adult
;
Arteriovenous Malformations/diagnosis/*surgery
;
Female
;
Humans
;
Magnetic Resonance Angiography
;
Migraine Disorders/diagnosis/*surgery
;
Pulmonary Artery/*abnormalities
;
Pulmonary Veins/*abnormalities
;
Thoracotomy
;
Tomography, X-Ray Computed
4.A proposal of injection points of botulinum toxin into temporal region for chronic migraine.
Young Gun KIM ; Jung Hee BAE ; Seong Taek KIM
Journal of Dental Rehabilitation and Applied Science 2017;33(1):1-6
Botulinum toxin (BoNT) injections have been used not only in the field of cosmetic surgery such as forehead and eye wrinkle treatment but also in the treatment of chronic migraine, dystonia, spasticity, temporomandibular disorders (TMD). BoNT injections are the only approved therapies to date for prophylactic treatment of chronic migraine patients. Unlike the previously known paralysis of motor neurons, the mechanism of action for migraine is to block the release of non-cholinergic neurotransmitters such as substance P, CGRP, and glutamate, which are associated with peripheral sensitization and neurogenic inflammation in the sensory nerve, it is hypothesized that the signal is blocked. This review focuses on the analgesic effects of BoNT and suggests the direction for the development of injection methods for chronic migraine patients.
Botulinum Toxins*
;
Dystonia
;
Forehead
;
Glutamic Acid
;
Headache Disorders
;
Humans
;
Migraine Disorders*
;
Motor Neurons
;
Muscle Spasticity
;
Neurogenic Inflammation
;
Neurotransmitter Agents
;
Paralysis
;
Substance P
;
Surgery, Plastic
;
Temporal Lobe*
;
Temporomandibular Joint Disorders